A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.

A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.

Resources Index


The Science Behind Performance Enhancing Drugs

Performance enhancing drugs are constantly scrutinized, tracked, and tested for by the International Olympic Committee, US Anti-Doping Agency and World Anti-Doping Agency. This blog will provide details on some common performance enhancing drugs and measures to detect them.


Real World Collaboration: Accelerating Scientific Innovation in an Evolving World

Though we often think of scientific discovery as being driven by competition, going forward, one of the key questions is how we can achieve the optimal balance between collaboration and competition to enhance scientific innovation.


Coronavirus Variants: The Delta Variant and the Future Impact of Viral Mutations

If you are fully vaccinated, should you be worried about the impact of COVID-19 variants? Read this blog and learn about effectiveness of vaccines on Coronavirus variants.


CAS IP Research: Opportunities for Accelerating Innovation and Mitigating Risk at the Nexus of Intellectual Property and R&D

This CAS whitepaper explores the transformation of IP and R&D, where organizations apply IP insights to accelerate breakthroughs and identify potential risks to commercialization earlier in the product lifecycle.


Find a better route: Optimizing AI for more novel synthetic predictions

AI and machine learning models aid in retrosynthetic planning, but are limited by the training data they have seen. Read on to learn about ways to generate novel predictions by ensuring your data has the necessary diversity and quality to optimize key synthetic planning initiatives.


Latest data on the safety and effectiveness of COVID-19 vaccines in children

On May 10, 2021, the U.S. FDA granted an extension of the emergency use authorization for Pfizer/BioNTech’s COVID-19 vaccine for children ages 12-15 based on available safety and efficacy data. Read about the latest data.


Our evolution is a job that is never done

The work of scientific discovery is never done but is continuously improving, and such is also the case for CAS.

Press Releases

CAS launches new brand reflecting strategic evolution to empower smarter science

CAS launched a new brand reflecting the broadening scope of its solutions and capabilities critical to advancing scientific discovery. This new brand mirrors an on-going evolution to enable new and smarter uses of scientific information as a partner to R&D leaders pursuing more efficient, collaborative, and customized innovation models.


Novel oligonucleotide with application in mRNA vaccine quality control gets 250 millionth CAS Registry Number

Novel oligonucleotide from Moderna, with application in mRNA vaccine quality control, marks the 250 millionth substance registration in CAS REGISTRY.